19-03-2025
Bipartisan legislation focuses on prescription drug prices
Bipartisan legislation was reintroduced by Reps. Joe Courtney (D-CT) and Erin Houchin (R-IN), shining light on the prescription drug pricing system to provide fair deals to patients. The bill (320-71) was first introduced in 2023 by the House as part of the Lower Cost, More Transparency Act.
This legislation concerns in particular Pharmacy Benefit Managers, companies that manage prescription drug benefits for health insurers and others. They are the ones negotiate with the drug manufacturers and pharmacies, establishing the total cost for insurers, patient's access to medication and how much pharmacies are paid.
The issue, legislatures say, with PBM is they do not disclose the profits they earn from deals with drug companies.
